Preclinical Evaluation of 177Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors.

AAA614 - 3B Pharma, Novartis

177Lu-OncoFAP-23 - Philogen

http://www.ncbi.nlm.nih.gov/pubmed/39266289

Andrea Galbiati; Dario Neri; Domenico Ravazza; Ettore Gilardoni; Jacqueline Mock; Matilde Bocci; Samuele Cazzamalli

Sep 13, 2024